ftInvstr

AHCL · Healthcare ₹27.15 -2.44% Mkt Cap ₹1446 Cr

AHCL

Healthcare Drug Manufacturers - Specialty & Generic

★ Watchlist ⧉ Add to bucket

₹27.15

-2.44% today · 30d -3.42%

as of 2026-11-09

Price · Daily Candles

Detect candlestick pattern

AI narrative is temporarily unavailable for AHCL. The deterministic sections below render from live data.

₹ Latest Earnings · Q ending 2025-12-31

REVENUE

₹36 Cr

NET PROFIT

₹5 Cr

OPM

35.06%

EPS

₹1.13

PE 50.81

Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-1.6% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.

◇ Sector Position

PEERPEROCE %

AHCL50.81—

SUNPHARMA37.7921.44

DIVISLAB93.121.56

ZYDUSLIFE28.424.22

+ 2 more peers — sign in to view

ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

SCORE / 100

Overall

6-axis composite of the sections below.

Performance STRONG 100

Valuation STRETCHED 20

Growth STRONG 82

Profitability HIGH 95

Technicals STRONG 80

Risk MODERATE 60

Key Stats

TTM PE

50.81

P/B

4.37

52W HIGH

₹37.24

OFF HIGH

-27.09%

DIV YIELD

0.0%

MKT CAP

₹1446 Cr

◉ Active Signals

MACDBullish0.0574

RSI(14)Neutral53.22

⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold AHCL and at what entry.